Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
---|
01/05/2011 | CN101933895A Fenticonazole nitrate vaginal suppository composition |
01/05/2011 | CN101933863A Traditional Chinese medicine thin layer matter sanitary protecting cushion for treating pruritus vulvae |
01/05/2011 | CN101502524B Application of acetyl-fluorobenzene salicylamide compound in preparing anti-tumor medicament |
01/05/2011 | CN101502523B Application of benzoyl fluorobenzene salicylamide compound in preparing anti-tumor medicament |
01/05/2011 | CN101317875B Cornus officinalis processing method |
01/04/2011 | US7863445 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
01/04/2011 | US7863312 Pyrazolidinone derivatives, e.g., 4-[2-(2-(3-hydroxyoctyl)-5-oxopyrazolidin-1-yl)ethyl]benzoic acid; treating preterm labor, dysmenorrhea, asthma, hypertension, infertility, sexual disorders, undesired blood clotting, bone disorders, (pre)eclampsia, or eosinophil disorders |
01/04/2011 | US7863047 Intracorporeal medicaments for photodynamic treatment of disease |
01/04/2011 | CA2456901C Thieno[2,3-d]pyrimidines with combined lh and fsh agonistic activity |
01/04/2011 | CA2429312C Novel pyridine-substituted pyrazolopyridine derivatives |
12/30/2010 | US20100331420 Combination Therapies for the Treatment of Obesity |
12/30/2010 | US20100331419 Combination Therapies for the Treatment of Obesity |
12/30/2010 | US20100331404 Vector Delivery-Based Microbicides |
12/30/2010 | US20100331343 Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors |
12/30/2010 | US20100331337 Quercetin-Containing Compositions |
12/30/2010 | US20100331325 Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives |
12/30/2010 | US20100331310 Bicycloamine derivatives |
12/30/2010 | US20100331292 Substituted 16,17-annellated steriod compounds for use in womens healthcare |
12/30/2010 | US20100331270 Adrenomedullin production enhancer |
12/30/2010 | US20100330213 Estrogenic Extracts of Morus Alba and Uses Thereof |
12/30/2010 | US20100330212 Skin sensitizer delivery system |
12/30/2010 | US20100330163 Compositions and Methods for Enhancing Metal Ion Dependent Drug Therapies |
12/30/2010 | US20100330157 Biomaterial for the controlled delivery of ingredients |
12/30/2010 | US20100329987 Uses of Sperm Membrane Protein OBF |
12/30/2010 | US20100325915 Orthopedic insoles for protecting skin from stretching and cracking in the area of the five metatarsal heads of the forefoot |
12/29/2010 | WO2010150525A1 Urate transporter, as well as method and kit for evaluating urate transport-related disease factor and inflammation-related disease factor, and test sample and drug |
12/29/2010 | WO2009141835A3 Formulations, herbal medicated threads and preparing processes thereof |
12/29/2010 | EP2267026A1 Albumin fusion proteins |
12/29/2010 | EP2266624A2 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections |
12/29/2010 | EP2266577A1 Multi-substitued selective androgen receptor modulators and methods of use therof |
12/29/2010 | EP2266573A1 Fulvestrant formulation |
12/29/2010 | EP2266568A1 Use of LHRH antagonists in combination with PDE V inhibitors for the treatment of sex hormone dependent disorders |
12/29/2010 | EP2266567A1 Use of cetrorelix in combination with PDE V inhibitors for the treatment of sex hormone dependent disorders |
12/29/2010 | EP2266561A2 IKK Inhibitors for the Treatment of Endometriosis |
12/29/2010 | EP2266560A1 Benzothiophenes, formulations containing same, and methods |
12/29/2010 | EP1370530B1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical |
12/29/2010 | EP1077678B1 Mucoadhesive compositions for administration of biologically active agents to animal tissue |
12/29/2010 | CN101932331A Methods for in vitro maturation of ovarian follicles |
12/29/2010 | CN101928745A Preparation method and applications of ant polypeptide |
12/29/2010 | CN101928342A High-purity menopausal gonadotropin as well as preparation method and application thereof |
12/29/2010 | CN101928262A Biologically active methylene blue derivatives |
12/29/2010 | CN101926961A Oral Chinese medicinal composition for treating pelvic inflammatory disease |
12/29/2010 | CN101926956A Chinese medicinal powder for treating mazoitis, hyperplasia of mammary glands and breast cancer |
12/29/2010 | CN101926953A Medicinal liquor for curing impotence, enhancing sexual function and strengthening constitution |
12/29/2010 | CN101926940A Method for preparing medicinal toilet paper for preventing and treating female diseases |
12/29/2010 | CN101926927A Preparation method of medicament for treating impotence and premature ejaculation |
12/29/2010 | CN101926917A Chinese medicinal composition for treating excessive menstruation |
12/29/2010 | CN101926914A Galactagog and food two-purpose instant herbal medicine for lying-in woman and preparation method thereof |
12/29/2010 | CN101926912A Oral health-care beautifying soup for preventing breast disease |
12/29/2010 | CN101926909A Externally applied medicine liquor for treating mammary gland hyperplasia |
12/29/2010 | CN101926887A Quality control method of medicinal preparation for treating gynecological inflammation and hysteromyoma |
12/29/2010 | CN101926880A Chinese medicinal composition for treating amenorrhea and endometritis of women |
12/29/2010 | CN101926875A Gel for treating gynecologic inflammation and preparation method thereof |
12/29/2010 | CN101926863A Method for identifying Nigella glandulifera Freyn medicinal material |
12/29/2010 | CN101926810A Application of carthamin to preparing drug for treating climacteric syndrome |
12/29/2010 | CN101926806A Application of 17 phosphorus estrogen compound in preparation of emergency contraception |
12/29/2010 | CN101926789A Improved topical medicaments and methods for photodynamic treatment of disease |
12/29/2010 | CN101926783A Drug slow control releaser and preparation method thereof |
12/29/2010 | CN101926782A Oral solid drug compound containing dienogest |
12/29/2010 | CN101926758A Itraconazole suppository |
12/29/2010 | CN101658330B Traditional Chinese medicine physical therapy pants for treating female reproductive system diseases |
12/29/2010 | CN101485666B Application of Gamabufotalin and salt thereof in preparing medicament for treating gynaecologic tumor |
12/29/2010 | CN101445542B Process for preparing desogestrel |
12/29/2010 | CN101433654B Chinese medicine preparation for treating women's chronic pelvic inflammatory disease and preparation method thereof |
12/29/2010 | CN101391077B Preparation method of traditional Chinese medicine for treating chronic pelvic inflammatory disease |
12/29/2010 | CN101342357B Chinese medicinal composition for treating gland hyperplasia and preventing and controlling mammary cancer |
12/29/2010 | CN101214270B Acanthopanax senticosus effective fraction extract, preparation and application thereof |
12/29/2010 | CN101142193B Propane-1,3-dion derivative or salt thereof |
12/29/2010 | CN101098702B Drugs, food or drink for improving pancreatic functions |
12/29/2010 | CN101036701B Chinese traditional medicine lotion |
12/29/2010 | CA2784286A1 Urate transporter, method and kit for evaluating urate transport-related disease factor and inflammation-related disease factor, and test sample and drug |
12/29/2010 | CA2765997A1 Treatment of endometriosis |
12/28/2010 | US7858662 Medicament for the treatment of viral skin and tumour diseases |
12/28/2010 | US7858641 melanocortin-4 receptor (MC4-R) agonists such as (3R,5S)-N-(2-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-1-oxo-1,2-dihydroisoquinolin-6-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used for the treatment of obesity or diabetes |
12/28/2010 | US7858631 such as (3R,5S)-N-(3-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-7-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used as melanocortin-4 receptor (MC4-R) agonists, for the treatment of obesity or diabetes |
12/28/2010 | US7858605 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
12/23/2010 | WO2010147234A1 Diarylamide-spirodiamine derivative |
12/23/2010 | WO2010147226A1 Pyrazinooxazepine derivatives |
12/23/2010 | WO2010147184A1 Prophylactic and/or therapeutic agent for dysmenorrhea |
12/23/2010 | WO2010146622A1 Nfat signal inhibitor and calcineurin inhibitor |
12/23/2010 | WO2010146407A1 Nanostructured sildenafil base, its pharmaceutically acceptable salts and co-crystals, compositions of them, process for the preparation thereof and pharmaceutical compositions containing them |
12/23/2010 | WO2010146313A2 Use of a composition comprising mother-of-pearl and optionally active substances of cocos nucifera as a nutritive medium that can dilute reproductive cells |
12/23/2010 | WO2010146310A1 Mother-of-pearl composition for correcting implantation problems in mammals |
12/23/2010 | WO2010145010A1 Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators |
12/23/2010 | WO2010126528A9 Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination |
12/23/2010 | US20100324070 Indole, indazole and benzimidazole arylamides as p2x3 and p2x2/3 antagonists |
12/23/2010 | US20100324037 Pharmacokinetically improved compounds |
12/23/2010 | US20100324021 (dihydro)imidazoiso[5,1-a]quinolines |
12/23/2010 | US20100324006 Hormone delivery system and method |
12/23/2010 | US20100324000 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptors |
12/23/2010 | US20100323999 Therapeutic Molecules and Methods-1 |
12/23/2010 | US20100323997 Novel uses |
12/23/2010 | US20100323960 Methods of Use of Biomaterial and Injectable Implant Containing Biomaterial |
12/23/2010 | US20100323950 Use of beta-melanotropin as a therapeutic agent, eg for the treatment of aids or alzheimer |
12/23/2010 | US20100323039 Labisia pumila extracts for reducing the risk of cardiovascular diseases |
12/23/2010 | US20100322997 Method for producing biologically ingestible microparticles, biologically ingestible microparticles, and dispersion and pharmaceutical composition containing the same |
12/23/2010 | CA2765847A1 Prophylactic and/or therapeutic agent for dysmenorrhea |
12/23/2010 | CA2765446A1 Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators |
12/22/2010 | EP2264028A1 Pyrazole compounds useful as protein kinase inhibitors |
12/22/2010 | EP2263709A1 Medical device having hydration inhibitor |